Romanian pharmaceutical producer Antibiotice to benefit from EIB guidance on strengthening corporate governance and investment capacity EIB to advise Romanian medicines manufacturer Antibiotice on updating its corporate governance Cooperation aims to strengthen company’s capacity to attract financing and support strategic …
File Type: pdf
* DIGI will post Q1 2026 preliminary result on May 15. * For the quarter, we estimate DIGI’s net turnover at EUR 603.7m, up 14% Y/Y, driven by continued expansion in Romania and Spain. Romania may increase 11% Y/Y to …
BET 30.090,61 +0,25% | Turnover $ 36.72mn | YTD +23,13% ****************************************************************** * TRP RO: TeraPlast Swings to Q1 Loss as Extended Winter and Hungary Elections Weigh on Construction Demand | NEGATIVE TeraPlast (TRP RO) reported a Q1 2026 net …
BET 30.090,61 +0,25% | Turnover $ 36.72mn | YTD +23,13% ****************************************************************** WIG20 Index : 3518,79 -1,88% USD 612mn BUX Index : 132484,90 -1,33% USD 65mn PX Index : 2502,50 -1,02% USD 22mn Market cap. USD 134.584 bio ******************************* (+) …
TRP RO: Q1 2026 Results | NEGATIVE TRP RO: Weak Q1 2026, with gross margin resilience insufficient to offset the impact of lower volumes | NEGATIVE * TeraPlast reported a weak Q1 2026, with revenues down 6% Y/Y to RON 235.5m, as …
